Finance · Single Stock Premium
JPM Premium Analysis: 4-Analyst Deep Dive
JPM — Premium 4-Analyst Analysis
JPMorgan Chase & Co. (NYSE: JPM) | May 8, 2026, 06:00 HKT
Status: PREMIUM | Framework: 4-Analyst | Slot: 0600
---
Recommendation Summary
| Analyst | Verdict | Key Signal |
|---|---|---|
| --------- | --------- | ------------ |
| **Fundamental** | BUY | Q1 EPS $5.94 (+17% YoY), strong NII growth, dividend yield 2.1% |
| **Technical** | HOLD | Above SMA200, RSI neutral 45.7, 50DMA below 200DMA (bearish) |
| **Sentiment** | BUY | 34 analysts, median target $338, Buy consensus |
| **Risk Manager** | BUY | 7.9% from 52w high, strong CET1 14.3%, moderate vol |
---
1. Fundamental Analysis
Current Price: $307.65 | 52-Week Range: $244.08 – $334.16 | Market Cap: ~$870B
Q1 2026 Earnings Scorecard
JPM posted blockbuster Q1 2026 results on April 14, beating on all major metrics:
| Metric | Q1 2026 | Q1 2025 | YoY Change |
|---|---|---|---|
| -------- | --------- | --------- | ------------ |
| Net Income | $16.5B | $14.6B | **+13%** |
| Diluted EPS | $5.94 | $5.07 | **+17%** |
| Total Revenue | $49.8B | $45.3B | **+10%** |
| Net Interest Income | $23.3B | $21.4B | **+9%** |
| Markets Revenue | $7.1B | $5.9B | **+21%** |
| Provision for Credit Losses | $2.5B | $3.3B | **-24%** |
Key Fundamental Metrics
| Metric | Value | Context |
|---|---|---|
| -------- | ------- | --------- |
| P/E (TTM) | 15.7x | Below 5-year average of 17.2x |
| P/B | 2.5x | Premium to peers, justified by ROE |
| Dividend Yield | 2.1% ($6.00/share annualized) | 28% payout ratio |
| EPS 2026E | $21.91–$23.49 | 8–10% growth expected |
| CET1 Ratio | 14.3% | Well above regulatory minimum (10.5%) |
| NII 2026 Guidance | ~$103B | Slightly lowered from $104.5B |
Bull Case
Bear Case
Preliminary Verdict: BUY
JPM trades at 15.7x P/E with 17% EPS growth, well above sector average. Strong free cash flow generation supports ongoing capital returns. Valuation still below 5-year average despite strong execution.---
2. Technical Analysis
Charts as of May 7, 2026 (251 trading days of data)
Price & Moving Averages
| Indicator | Value | Signal |
|---|---|---|
| ----------- | ------- | -------- |
| Current Price | $307.65 | — |
| SMA20 | $310.26 | Price **below** SMA20 |
| SMA50 | $298.61 | Price **above** SMA50 |
| SMA200 | $302.36 | Price **above** SMA200 |
| 52-Week High | $334.16 | -7.93% from high |
| 52-Week Low | $244.08 | +26.0% from low |
| RSI(14) | 45.69 | **Neutral** — neither overbought nor oversold |
Trend & Pattern Analysis
Support & Resistance
| Level | Type | Strength |
|---|---|---|
| ------- | ------ | ---------- |
| $334.16 | Resistance | 52-week high |
| $315.00 | Resistance | Previous support turned resistance |
| $307.65 | Current | Market price |
| $302.36 | Support | SMA200 — critical juncture |
| $298.61 | Support | SMA50 |
| $290.00 | Support | Horizontal cluster |
| $244.08 | Support | 52-week low |
Technical Verdict: HOLD
While price holds above SMA200, the bearish moving average alignment (50 < 200) is a warning flag. RSI neutral at 45.7 suggests room to move either direction. A break above SMA20 ($310.26) with volume confirmation would turn technicals bullish.
---
3. Sentiment Analysis
Data as of May 8, 2026
Analyst Consensus
| Source | Analysts | Average Target | Median Target | Range |
|---|---|---|---|---|
| -------- | ---------- | ---------------- | --------------- | ------- |
| Wall Street | 34 | $336.81 | $338.00 | $288–$391 |
| Barclays (High) | Jason Goldberg | — | $391.00 | Top pick |
| Consensus Rating | — | — | **BUY** | 16 Buy / 0 Sell |
Analyst Highlights
Recent News Flow
| Event | Impact |
|---|---|
| ------- | -------- |
| Q1 2026 earnings beat | **Positive** — EPS $5.94 vs est $5.40 |
| Fixed income trading +21% | **Very Positive** — beat by $370M |
| NII guidance lowered to $103B | **Mildly Negative** — rate margin concerns |
| Apple Card portfolio acquisition | **Positive** — long-term strategic |
| Jamie Dimon's leadership | **Positive** — confidence in execution |
Macro Sentiment
Sentiment Verdict: BUY
Bullish analyst consensus with 34 analysts covering and zero sell ratings. Q1 earnings beat, strong trading revenue, and improving credit quality support constructive outlook. Macro tailwinds from potential rate cuts and deregulation.
---
4. Risk Management
Volatility Metrics
| Metric | Value | Assessment |
|---|---|---|
| -------- | ------- | ------------ |
| Beta | ~1.1 | In line with sector |
| 30-Day Volatility | Moderate | Near sector average |
| Distance from 52w High | -7.93% | Healthy pullback |
| Distance from 52w Low | +26.04% | Well above floor |
| Max Drawdown (current) | ~8% from recent high | Normal correction |
Risk Factors
| Risk | Severity | Probability | Mitigation |
|---|---|---|---|
| ------ | ---------- | ------------- | ------------ |
| Interest rate decline | Medium | Medium | Diversified revenue streams |
| Credit cycle deterioration | Medium | Low | Strong provisions, low NPLs |
| Recession risk | Medium | Medium | Consumer bank resilience |
| Regulatory changes | Low | Medium | Best-in-class compliance |
| Trading revenue volatility | High | Medium | Diversified across FICC |
Position Sizing Guidelines
| Risk Profile | Max Allocation | Stop-Loss | Rationale |
|---|---|---|---|
| -------------- | ---------------- | ----------- | ------------ |
| **Conservative** | 5% | -10% ($277) | Quality bank, lower vol |
| **Moderate** | 10% | -15% ($261) | Balanced risk/reward |
| **Aggressive** | 15% | -20% ($246) | Strong conviction, higher vol tolerance |
Risk-Adjusted Assessment
Risk Score: MEDIUM
JPM's diversified business model, strong capital position (CET1 14.3%), and improving credit quality reduce downside risk. However, trading revenues are inherently volatile, and rate sensitivity keeps NII guidance under pressure. Current price 7.9% below 52-week high provides reasonable entry point.
Risk Manager Verdict: BUY (with stop-loss discipline)
---
Analyst Debate Summary
Points of Contention
1. Technical vs Fundamental: Technical flagged bearish MA alignment; Fundamental dismissed based on strong earnings. Resolution: Both valid — technical weakness is short-term noise; fundamentals justify long-term position.
2. NII Guidance Cut: Sentiment noted $1.5B guidance reduction as mildly negative. Fundamental emphasized this is due to deposit repricing, not credit issues. Resolution: Accept management guidance but watch for upside surprises.
3. Valuation: Price at $307.65 vs 34-analyst median target of $338 represents 9.9% upside. Risk Manager questioned whether current risk/reward warrants new positions at these levels. Resolution: For new positions, wait for pullback to $295–$300; existing positions hold.
Convergence Points
---
Final Investment Thesis
Ticker: JPM | Recommendation: BUY | Target: $338 | Horizon: 6–12 months
Investment Highlights
1. Earnings momentum: Q1 2026 delivered 17% EPS growth, beating expectations across all segments 2. Trading strength: Markets revenue +21% demonstrates institutional franchise durability 3. Credit improvement: Provision down 24% signals benign credit cycle 4. Capital return: ~$6/share annual dividends + buybacks provide floor 5. Valuation: 15.7x P/E below 5-year average, 10% upside to target
Entry Strategy
| Scenario | Entry Price | Target | Return |
|---|---|---|---|
| ---------- | ------------- | -------- | -------- |
| Aggressive (now) | $307.65 | $338 | +9.9% |
| Ideal (pullback) | $295–$300 | $338 | +13–15% |
| Conservative (wait) | $290 | $338 | +16.5% |
Key Catalysts
---
Data Sources
---
Premium analysis generated by 4-Analyst Framework. For informational purposes only. Not investment advice. Past performance does not guarantee future results.
Next update: May 8, 2026 12:00 HKT
此文章為 PREMIUM 會員專屬內容
訂閱 PREMIUM — HKD $188/月